Cell Robotics Licenses BD Patent for Laser-Assisted Blood Sampling
ALBUQUERQUE, NM, Jan. 31 -- Cell Robotics International Inc. has extended its intellectual property coverage of the Lasette product line by licensing a key patent from BD (formerly Becton, Dickinson and Co.) of Franklin Lakes, N.J. Specific terms and conditions of the agreement were not disclosed.
Ronald K. Lohrding, Cell Robotics' president and CEO, said, "We are delighted to have successfully completed this agreement with BD. Combining Cell Robotics' patents on various aspects of laser finger perforation with the license to BD's intellectual property provides us with very strong patent protection for this revolutionary Lasette product line."
The hand-held Lasette is the only FDA-cleared medical device that uses a special wavelength of laser light to obtain a capillary blood sample used for glucose readings and clinical blood screening tests.
LATEST NEWS
- Exail Signs LLNL Contract, Partners with Eelume
Apr 26, 2024
- Menlo Moves U.S. HQ: Week in Brief: 4/26/2024
Apr 26, 2024
- Optofluidics Platform Keys Label-, Amplification-Free Rapid Diagnostic Tool
Apr 25, 2024
- DUV Lasers Made with Nonlinear Crystals Enhance Lithography Performance
Apr 25, 2024
- Teledyne e2v, Airy3D Collaborate on 3D Vision Solutions
Apr 24, 2024
- One-Step Hologram Generation Speeds 3D Display Creation
Apr 24, 2024
- Innovation Award Winners for Laser Technology Honored in Aachen
Apr 23, 2024
- Intech 2024: AI Arrives on the Shop Floor
Apr 22, 2024